{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:31:55Z","timestamp":1779294715640,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2022NSFSC1394"],"award-info":[{"award-number":["2022NSFSC1394"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bbrc.2023.10.050","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T02:34:53Z","timestamp":1697250893000},"page":"149118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Cytokines as drivers: Unraveling the mechanisms of epithelial-mesenchymal transition in COVID-19 lung fibrosis"],"prefix":"10.1016","volume":"686","author":[{"given":"Lanlan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuansheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2023.10.050_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrneph.2009.74","article-title":"Fibroblast activation and myofibroblast generation in obstructive nephropathy","volume":"5","author":"Grande","year":"2009","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbrc.2023.10.050_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12989-021-00404-3","article-title":"Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19","volume":"18","author":"Li","year":"2021","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.bbrc.2023.10.050_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12306-008-0064-1","article-title":"Growth factors in bone repair","volume":"92","author":"Devescovi","year":"2008","journal-title":"Chir. Organi Mov."},{"key":"10.1016\/j.bbrc.2023.10.050_bib4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.phrs.2008.06.007","article-title":"The immune system and cardiac repair","volume":"58","author":"Frangogiannis","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2023.10.050_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1513\/pats.200711-168DR","article-title":"Fibrogenesis of parenchymal organs","volume":"5","author":"Kisseleva","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.bbrc.2023.10.050_bib6","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.2174\/092986709787846497","article-title":"Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast","volume":"16","author":"Gharaee-Kermani","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.10.050_bib7","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1440-1746.2008.05345.x","article-title":"Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?","volume":"23","author":"Gressner","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2023.10.050_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01346-2019","article-title":"TRIM33 prevents pulmonary fibrosis by impairing TGF-\u03b21 signalling","volume":"55","author":"Boutanquoi","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbrc.2023.10.050_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01949-2019","article-title":"NADPH oxidase DUOX1 sustains TGF-\u03b21 signalling and promotes lung fibrosis","volume":"57","author":"Louzada","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbrc.2023.10.050_bib10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1183\/09031936.00011810","article-title":"Overexpression of transforming growth factor-beta1 in fetal monkey lung results in prenatal pulmonary fibrosis","volume":"36","author":"Tarantal","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbrc.2023.10.050_bib11","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm888","article-title":"BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury","volume":"9","author":"Zeisberg","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2023.10.050_bib12","doi-asserted-by":"crossref","first-page":"23337","DOI":"10.1074\/jbc.M700194200","article-title":"Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition","volume":"282","author":"Zeisberg","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2023.10.050_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature16064","article-title":"Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer","volume":"527","author":"Zheng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2023.10.050_bib14","first-page":"2278","article-title":"Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail","volume":"11","author":"Lai","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbrc.2023.10.050_bib15","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1038\/onc.2015.328","article-title":"LZTFL1 suppresses lung tumorigenesis by maintaining differentiation of lung epithelial cells","volume":"35","author":"Wei","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2023.10.050_bib16","article-title":"Microvascular significance of TGF-\u03b2 axis activation in COVID-19","volume":"9","author":"Arguinchona","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.bbrc.2023.10.050_bib17","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/1873-3468.14104","article-title":"Serum levels of the IgA isotype switch factor TGF-\u03b21 are elevated in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2023.10.050_bib18","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJMc1915189","article-title":"Reversal of TGF\u03b21-driven profibrotic state in patients with pulmonary fibrosis","volume":"382","author":"Chapman","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2023.10.050_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090353","article-title":"Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGF\u03b2) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma","volume":"9","author":"Morris","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2023.10.050_bib20","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1164\/rccm.202205-0868LE","article-title":"Randomized phase IIa clinical study of an anti-\u03b1(v)\u03b2(6) monoclonal antibody in idiopathic pulmonary fibrosis","volume":"206","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbrc.2023.10.050_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41588-021-01006-7","article-title":"Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease","volume":"54","author":"Horowitz","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2023.10.050_bib22","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa2020283","article-title":"Genomewide association study of severe covid-19 with respiratory failure","volume":"383","author":"Ellinghaus","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2023.10.050_bib23","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41588-021-00955-3","article-title":"Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus","volume":"53","author":"Downes","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2023.10.050_bib24","series-title":"Interleukin, StatPearls, StatPearls Publishing Copyright \u00a9 2023","author":"Justiz Vaillant","year":"2023"},{"key":"10.1016\/j.bbrc.2023.10.050_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2023.10.050_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102567","article-title":"Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions","volume":"19","author":"Jamilloux","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbrc.2023.10.050_bib27","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2023.10.050_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s13054-020-03166-0","article-title":"Blocking IL-1 to prevent respiratory failure in COVID-19","volume":"24","author":"van de Veerdonk","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.bbrc.2023.10.050_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1476-4598-11-87","article-title":"IL-1\u03b2 promotes stemness and invasiveness of colon cancer cells through Zeb1 activation","volume":"11","author":"Li","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2023.10.050_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2020.09.051","article-title":"A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients","volume":"27","author":"Petrone","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bbrc.2023.10.050_bib31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/dgd.12630","article-title":"Interleukin-2 induces extracellular matrix synthesis and TGF-\u03b22 expression in retinal pigment epithelial cells","volume":"61","author":"Jing","year":"2019","journal-title":"Dev. Growth Differ."},{"key":"10.1016\/j.bbrc.2023.10.050_bib32","first-page":"567","article-title":"E2F1\/SP3\/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells","volume":"53","author":"Chen","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2023.10.050_bib33","first-page":"567","article-title":"E2F1\/SP3\/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells","volume":"53","author":"Chen","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2023.10.050_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75659-5","article-title":"IL-4\/IL-13 remodeling pathway of COVID-19 lung injury","volume":"10","author":"Vaz de Paula","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2023.10.050_bib35","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/labinvest.2013.69","article-title":"M2-polarized tumor-associated macrophages promoted epithelial\u2013mesenchymal transition in pancreatic cancer cells, partially through TLR4\/IL-10 signaling pathway","volume":"93","author":"Liu","year":"2013","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2023.10.050_bib36","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/ijc.32151","article-title":"IL-10 derived from M2 macrophage promotes cancer stemness via JAK1\/STAT1\/NF-\u03baB\/Notch1 pathway in non-small cell lung cancer","volume":"145","author":"Yang","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2023.10.050_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1871530321666210127141945","article-title":"An alternative \"trojan horse\" hypothesis for COVID-19: immune deficiency of IL-10 and SARS-CoV-2 biology","volume":"22","author":"Balzanelli","year":"2022","journal-title":"Endocr., Metab. Immune Disord.: Drug Targets"},{"key":"10.1016\/j.bbrc.2023.10.050_bib38","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.bbrc.2023.10.050_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","volume":"146","author":"Li","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbrc.2023.10.050_bib40","article-title":"IL-13 is a driver of COVID-19 severity","volume":"6","author":"Donlan","year":"2021","journal-title":"JCI insight"},{"key":"10.1016\/j.bbrc.2023.10.050_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13502","article-title":"Dupilumab and COVID\u201019: what should we expect?","volume":"33","author":"Patruno","year":"2020","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.bbrc.2023.10.050_bib42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jaci.2020.03.045","article-title":"An anti\u2013IL-13 antibody reverses epithelial-mesenchymal transition biomarkers in eosinophilic esophagitis: phase 2 trial results","volume":"146","author":"Gann","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbrc.2023.10.050_bib43","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/cbin.10964","article-title":"Propofol prevents IL-13-induced epithelial-mesenchymal transition in human colorectal cancer cells","volume":"42","author":"Xu","year":"2018","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bbrc.2023.10.050_bib44","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1159\/000494241","article-title":"TGF\u03b21-Smad signaling pathway participates in interleukin-33 induced epithelial-to-mesenchymal transition of A549 cells","volume":"50","author":"Tan","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbrc.2023.10.050_bib45","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3389\/fimmu.2020.01598","article-title":"Epithelial-mesenchymal transition in asthma airway remodeling is regulated by the IL-33\/cd146 Axis","volume":"11","author":"Sun","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2023.10.050_bib46","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jaci.2014.05.011","article-title":"IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice","volume":"134","author":"Li","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbrc.2023.10.050_bib47","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.18632\/aging.102707","article-title":"The Interleukin-33\/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation","volume":"12","author":"Lin","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbrc.2023.10.050_bib48","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jaci.2017.01.015","article-title":"IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs","volume":"140","author":"Chen","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbrc.2023.10.050_bib49","doi-asserted-by":"crossref","first-page":"e779","DOI":"10.1016\/S2665-9913(20)30340-4","article-title":"Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?","volume":"2","author":"Zizzo","year":"2020","journal-title":"Lancet Rheumatol"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23012019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23012019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:48:57Z","timestamp":1762094937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X23012019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":49,"alternative-id":["S0006291X23012019"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.10.050","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokines as drivers: Unraveling the mechanisms of epithelial-mesenchymal transition in COVID-19 lung fibrosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.10.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"149118"}}